finamine
/ Shijiazhuang Yiling Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
December 14, 2021
A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China
(clinicaltrials.gov)
- P1; N=34; Completed; Sponsor: Yiling Pharmaceutical Inc.; Active, not recruiting ➔ Completed
Clinical • Trial completion • CNS Disorders • Movement Disorders • Parkinson's Disease
July 02, 2020
A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China
(clinicaltrials.gov)
- P1; N=34; Active, not recruiting; Sponsor: Yiling Pharmaceutical Inc.; Trial completion date: Dec 2019 ➔ Dec 2020
Clinical • Trial completion date • CNS Disorders • Gene Therapies • Movement Disorders • Parkinson's Disease
1 to 2
Of
2
Go to page
1